![logo](/logos/QLI.webp)
Qilian International Holding Group Limited
NASDAQ:QLI
5.41 (USD) • At close August 9, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Qilian International Holding Group Limited |
Symbool | QLI |
Munteenheid | USD |
Prijs | 5.41 |
Beurswaarde | 38,681,500 |
Dividendpercentage | 0% |
52-weken bereik | 1.776 - 6.69 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Zhanchang Xin |
Website | https://www.qlsyy.net |
An error occurred while fetching data.
Over Qilian International Holding Group Limited
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)